Expanded Surveillance for Pediatric Infectious Diseases
Agency: Centers for Disease Control and Prevention - ERA
- 93.083 -- Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases
Forecasted opportunityLast Updated: Jul 29, 2026
Important dates
- Forecasted post date: October 30, 2026
- Forecasted application due date: December 31, 2026
- Forecasted award date: July 30, 2027
- Forecasted project start date: September 1, 2027
- Fiscal Year: 2027
Award details
- Expected project funding: $40,000,000
- Expected awards: 7
Award min.
$850,000
Award max.
$1,140,000
- Funding opportunity number:RFA-IP-27-035
- Cost sharing or matching requirement:No
- Funding instrument type:
- Cooperative agreement
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Forecast posted date: July 28, 2026
- Archive date: January 30, 2027
- Version: 3
Summary
The purpose of this Notice of Funding Opportunity (NOFO) is to support a network of U.S. institutions that will conduct standardized, prospective, active surveillance of pediatric acute respiratory illness (ARI) and acute gastroenteritis (AGE). The network will focus on respiratory and enteric viruses among pediatric patients seeking healthcare.
In addition, the network will generate robust estimates of the effectiveness of influenza, rotavirus, respiratory syncytial virus (RSV) and other prevention products against respiratory and enteric viral illnesses in this population.
Recipients will identify AGE and ARI illnesses among patients seeking healthcare or diagnostic testing for acute illness among inpatient and emergency department populations. Recipients may also include patients seeking care in outpatient clinics, such as urgent care centers, as an optional activity.
This is a multi-component NOFO. You must apply for ComponentA (Core Component). You may also apply for one or more optional components.
Component A – Core Component (Required)
- Support inpatient and emergency department pediatric surveillance
- Follow the standardized protocol established by CDC
Optional Components
- Component B: Support outpatient pediatric surveillance
- Component C: Study immune response and infection
- Component D: Study immune response and immunization
Recipients will enroll patients meeting standard symptom criteria and confirm viral infections using approved molecular assays. The network will use the data to estimate prevention product effectiveness, hospitalization rates, and information on the natural history of medically attended diseases.
Findings of this NOFO will:
- Improve best practices for diagnosis and treatment protocols
- Inform prevention product recommendations
- Guide public health strategies
- Reduce viral illness-associated hospitalizations and healthcare utilization among children
Eligibility
Government
- Public and Indian housing authorities
- Federally recognized Native American tribal governments
- Special district governments
- City or township governments
- State governments
- County governments
Nonprofit
- Nonprofits non-higher education without 501(c)(3)
- Other Native American tribal organizations
- Nonprofits non-higher education with 501(c)(3)
Business
- For-profit organizations other than small businesses
Education
- Independent school districts
- Public and state institutions of higher education
- Private institutions of higher education
Additional information on eligibility
Documents
No documents are currently available.
Link to additional information
No additional information is available
